Canopus marker navigation for breast surgery
Part of Cancer clinical trials.
This trial tests a new surgical marker called Canopus that helps doctors find and remove breast tumors or affected lymph nodes during surgery. It may help you get more precise treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a single breast tumor (either non-invasive or invasive) that can be seen on ultrasound.
- You are scheduled for breast-conserving surgery or a targeted lymph node removal.
- Your doctor plans to place one marker in the tumor and/or one marker in a lymph node before surgery.
- You are not pregnant or breastfeeding.
- You do not have a pacemaker or other active implant near the area where the marker will be placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a magnetic marker system (placed in the breast or armpit area) to help surgeons find and remove a suspicious lump or lymph node. If you’re having breast/axillary lesion or node removal, this may help guide the procedure.
This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.
This study uses a tiny magnetic marker (called Magseed) placed in a breast cancer–affected underarm lymph node, then tracks whether surgeons can find and remove the correct nodes after chemotherapy. It may help reduce the chance of missing cancer in the underarm while aiming for more accurate surgery.
This trial compares two techniques for pinpointing non-touchable breast cancer during breast-conserving surgery. The study aims to see which method is more accurate and whether it leads to better surgical outcomes.
This trial compares two techniques for finding breast tumors that cannot be felt by hand after initial (neoadjuvant) treatment. If successful, it may make breast-conserving surgery more accurate when the tumor has become “non-palpable.”
This trial tests a new ultrasound marker to help surgeons find and remove cancer-positive lymph nodes during breast cancer surgery. The marker makes the node easier to see on ultrasound so it can be taken out accurately.
Hear when a new Breast Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.